Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 189

Sort by

Sort Order Select

Journal Articles

A Phase II Trial of Ibrutinib and PD-1 Blockade in Asymptomatic High Risk Chronic Lymphocytic Leukemia to Improve Immune Function

Julio C. Chavez, MD, Ariel F Grajales-Cruz, MD, Virginia Olivia Volpe, MD, Elyce P. Turba, MSN, RN, Lisa Nodzon, PhD ARNP, AOCNP, Eva Sahakian, PhD, Nicole Rozario, Javier Pinilla Ibarz, MD PhD

Blood (2019) 134 (Supplement_1): 5483.

https://doi.org/10.1182/blood-2019-132211

Published: 2019

Journal Articles

Large Granular Lymphocytic Leukemia Coexists with Clonal Hematopoiesis of Indeterminate Potential

Jibran Durrani, Hassan Awada, Ashwin Kishtagari, MBBS, Cassandra M Kerr, MS, Vera Adema, PhD, Yasunobu Nagata, MD PhD, Teodora Kuzmanovic, Sanghee Hong, MD, Sunisa Kongkiatkamon, Alan Lichtin, MD, Aziz Nazha, MD, Bhumika J. Patel, MD, Yogenthiran Saunthararajah, MD, Hetty E. Carraway, MD MBA, Valeria Visconte, PhD, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, MD PhD

Blood (2019) 134 (Supplement_1): 3743.

https://doi.org/10.1182/blood-2019-129330

Published: 2019

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Patients of 65 Years or Older: A Monocenter Analysis on 252 Patients

Blood (2019) 134 (Supplement_1): 4625.

https://doi.org/10.1182/blood-2019-131845

Published: 2019

Journal Articles

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

Nathanael Fillmore, PhD, Sarvari Venkata Yellapragada, MD, Cenk Yildirim, MS, Aimaz Afrough, MD, Adanma Anji Ayanambakkam Attanathi, MD, Ifeorah Chizoba, MPH, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 1806.

https://doi.org/10.1182/blood-2019-132227

Published: 2019

Journal Articles

Predictors of Transfer to Different Facility at Discharge in Patients Admitted with Hematologic Malignancy: A Nationwide Inpatient Sample (NIS) Database Analysis

Sunny R K Singh, MD, Sindhu Malapati, MD, Rohit Kumar, MD, Olekdandra Lupak, MD, Philip Kuriakose, MD

Blood (2019) 134 (Supplement_1): 2132.

https://doi.org/10.1182/blood-2019-127604

Published: 2019

Journal Articles

Treatment Patterns and Outcomes of 1205 Patients on Novel Agents in the US Veterans Health Administration (VHA) System: Results from the Largest Retrospective EMR and Chart Review Study in the Real-World Setting

Christopher R Frei, Hannah Le, PharmD, MPH, Daniel McHugh, Cynthia Elesinmogun, PharmD, Samantha Galley, Kathleen Franklin, Juan Tavera, Michelle Janania Martinez, MD, David J Gregorio, DO, Snegha Ananth, MBBS, Ricardo Uribe, Prathibha Surapaneni, Manuel Ricardo Espinoza-Gutarra, MD, Michael Song, Xavier Jones, Chengwen Teng, Obiageri O Obodozie-Ofoegbu, Zohra Nooruddin, MD

Blood (2019) 134 (Supplement_1): 795.

https://doi.org/10.1182/blood-2019-122434

Published: 2019

Journal Articles

Billed Palliative Care Services and End-of-Life Care in Patients with Hematologic Malignancies

Vinay B Rao, Emmanuelle Belanger, PhD, Pamela C Egan, MD, Thomas W. LeBlanc, MDMA,MHS, Adam J Olszewski, MD

Blood (2019) 134 (Supplement_1): 384.

https://doi.org/10.1182/blood-2019-121955

Published: 2019

Journal Articles

Beyond Acute Leukemia: Learner Perceptions of Inpatient Hematology Education and Deficiencies in Non-Malignant Topics

Andrew O'Brien, MD, Rakesh P. Mehta, MD

Blood (2019) 134 (Supplement_1): 5797.

https://doi.org/10.1182/blood-2019-123271

Published: 2019

Journal Articles

Chronic Myeloid Leukemia Incidence Based Estimates of Hematopoietic Stem Cell Numbers per Person

Tomas Radivoyevitch, Brian P. Hobbs, PhD, Yasunobu Nagata, Jacob Scott, MD, Asha Kallianpour, MD, Takuya Sakaguchi, PhD, Jaroslaw P. Maciejewski, Yasushi Miyazaki, MD PhD

Blood (2018) 132 (Supplement 1): 5441.

https://doi.org/10.1182/blood-2018-99-119583

Published: 2018

Journal Articles

Contribution of Flow Cytometry Immunophenotyping in Diagnostic of Acute and Chronic Leukemias

Aldair Sousa Paiva, PhD, Hugo Diogenes De Oliveira Paiva, MD, Geraldo Barroso Cavalcanti, Jr., PhD, Lenilton Silva Silveira, Jr., MD, Lorena KF Silva, Erica Aires Gil, MD, Roberto C Vasconcelos, MD, Frank Bahia, MD, Rodrigo Villar Freitas, MD, Dany GKC Silva, Valéria SF Sales, PhD, Alessandra Suelen Jardim, Victor lima Soares, James Farley Marciel

Blood (2018) 132 (Supplement 1): 5198.

https://doi.org/10.1182/blood-2018-99-118923

Published: 2018

Journal Articles

Literature Review of All Cases of Aggressive T-Cell Large Granular Lymphocytic Leukemia Cases and Report of an Additional Case

Vanessa Brunet, MD, Michel Pavic, MD, Sofia Marouan, Isabelle Fleury, MD MSc, FRCP, Jean-Francois Castilloux, MD

Blood (2018) 132 (Supplement 1): 5421.

https://doi.org/10.1182/blood-2018-99-111726

Published: 2018

Journal Articles

A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Stem Cell Transplant in Patients with Myelodysplastic Syndromes: On Behalf of the CIBMTR Chronic Leukemia Committee

Aziz Nazha, Zhen-Huan Hu, MPH, Tao Wang, PhD, Betty K. Hamilton, MD, Navneet S. Majhail, MD MS, R. Coleman Lindsley, MD, PhD, Ronald Sobecks, MD, Uday Popat, MD, Bart L Scott, MD, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 206.

https://doi.org/10.1182/blood-2018-99-118677

Published: 2018

Journal Articles

Patterns of Utilization and Outcome of Hematopoietic Stem Cell Transplantation Among Various Cancers: A Nationwide Analysis

Prabhjot Singh Bedi, MD, Manoj P Rai, MD, Justin D. Kaner, MD, Samanjit Kaur Kandola, MD, Varunsiri Atti, Shiva Shrotriya, MD MPH, Ikponmwosa Enofe, MD, Nishant Tageja, MD, Marwan S Abougergi, MD, Heather Laird-Fick, MD, James B. Bussel, MD, Stanley M. Marks, MD

Blood (2018) 132 (Supplement 1): 4749.

https://doi.org/10.1182/blood-2018-99-110744

Published: 2018

Journal Articles

Incidence and Risk Factors of CMV Reactivation after Haploidentical Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide - Possible Role of Donor KIR Genotypes

Monzr Al Malki, MD, Sanjeet Dadwal, MD, Dongyun Yang, PhD, Sally Mokhtari, PhD, Thai Cao, MD, Ketevan Gendzekhadze, David S Snyder, MD, Haris Ali, MD, Ibrahim Aldoss, MD, Amandeep Salhotra, MD, Guido Marcucci, Chatchada Karanes, Pablo Parker, MD, Auayporn P. Nademanee, MDBS, Don Diamond, PhD, John Zaia, MD, Stephen J Forman, Ryotaro Nakamura, MD

Blood (2018) 132 (Supplement 1): 3416.

https://doi.org/10.1182/blood-2018-99-113514

Published: 2018

Journal Articles

Does Early T Cell Chimerism Predict Outcomes after Allogeneic Hematopoietic Cell Transplantation ?

Tania Jain, MD, Luke Mountjoy, DO, Katie L. Kunze, PhD, Pierre Noel, MD, Nandita Khera, MD, Jose F. Leis, MD PhD, James L. Slack, MD, Lisa Z. Sproat, Jeanne Palmer, MD

Blood (2018) 132 (Supplement 1): 3360.

https://doi.org/10.1182/blood-2018-99-115287

Published: 2018

Journal Articles

Conditional Survival and Mortality Risks after Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Patients Who Survived Varying Length of Time after Allohct

F. Lennie Wong, PhD, Meisi Xiao, MPH, Jennifer Berano Teh, Liezl Atencio, Alicia Gonzales, Amy Hinton, David Iukuridze, Stephen J Forman, Ryotaro Nakamura, MD, Saro H. Armenian, DO,MPH

Blood (2018) 132 (Supplement 1): 368.

https://doi.org/10.1182/blood-2018-99-112646

Published: 2018

Journal Articles

Pre-Transplant and Peri-d100 Gastrointestinal Dysbiosis Is Associated with the Subsequent Development of Chronic Graft-Versus-Host Disease

Kate A Markey, PhDMBBS, Antonio LC Gomes, PhD, Eric R. Littmann, BA, Sean M Devlin, PhD, Ann E. Slingerland, BSc, John B. Slingerland, BSc, Annelie Clurman, BA, Gillian Moore, BA, Samira A Fatmi, BS, Molly Maloy, MS, Eric G. Pamer, MD, Ying Taur, MD MPH, Sergio Giralt, MD, Miguel-Angel Perales, MD, Doris Ponce, MD, Jonathan U. Peled, MD PhD, Marcel R.M. van den Brink, MD PhD

Blood (2018) 132 (Supplement 1): 359.

https://doi.org/10.1182/blood-2018-99-110309

Published: 2018

Journal Articles

Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia

Thomas W. LeBlanc, Pamela C. Egan, Adam J. Olszewski

Blood (2018) 132 (7): 717–726.

https://doi.org/10.1182/blood-2018-03-842575

Published: 2018

Includes: Supplemental data

Journal Articles

High Incidence of CMV Reactivation after Haploidentical Donor Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide, and Its Impact on Transplant Outcomes

Monzr M. Al Malki, MD, Sanjeet Dadwal, MD, Dongyun Yang, PhD, Sally Mokhtari, PhD, Thai Cao, MD, Ketevan Gendzekhadze, PhD, Ibrahim Aldoss, MD, Pablo Parker, MD, Margaret R. O'Donnell, MD, David S. Snyder, MD, David Senitzer, PhD, Joseph Rosenthal, MD MS, Auayporn P. Nademanee, MDBS, Don Diamond, PhD, John Zaia, MD, Stephen J. Forman, MD FACP, Ryotaro Nakamura, MD

Blood (2017) 130 (Supplement 1): 4494.

https://doi.org/10.1182/blood.V130.Suppl_1.4494.4494

Published: 2017

Journal Articles

Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Leukemia Cells

Katherine Sullivan, Elisabeth Bolton-Gillespie, Yashodhara Dasgupta, Samantha Langer, Micheal Siciliano, Margaret Nieborowska-Skorska, Huaqing Zhao, Peter Valent, Tomasz Skorski

Blood (2017) 130 (Supplement 1): 4623.

https://doi.org/10.1182/blood.V130.Suppl_1.4623.4623

Published: 2017

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

A Phase II Trial of Ibrutinib and PD-1 Blockade in Asymptomatic High Risk Chronic Lymphocytic Leukemia to Improve Immune Function

Large Granular Lymphocytic Leukemia Coexists with Clonal Hematopoiesis of Indeterminate Potential

Allogeneic Hematopoietic Stem Cell Transplantation in Patients of 65 Years or Older: A Monocenter Analysis on 252 Patients

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

Predictors of Transfer to Different Facility at Discharge in Patients Admitted with Hematologic Malignancy: A Nationwide Inpatient Sample (NIS) Database Analysis

Treatment Patterns and Outcomes of 1205 Patients on Novel Agents in the US Veterans Health Administration (VHA) System: Results from the Largest Retrospective EMR and Chart Review Study in the Real-World Setting

Billed Palliative Care Services and End-of-Life Care in Patients with Hematologic Malignancies

Beyond Acute Leukemia: Learner Perceptions of Inpatient Hematology Education and Deficiencies in Non-Malignant Topics

Chronic Myeloid Leukemia Incidence Based Estimates of Hematopoietic Stem Cell Numbers per Person

Contribution of Flow Cytometry Immunophenotyping in Diagnostic of Acute and Chronic Leukemias

Literature Review of All Cases of Aggressive T-Cell Large Granular Lymphocytic Leukemia Cases and Report of an Additional Case

A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Stem Cell Transplant in Patients with Myelodysplastic Syndromes: On Behalf of the CIBMTR Chronic Leukemia Committee

Patterns of Utilization and Outcome of Hematopoietic Stem Cell Transplantation Among Various Cancers: A Nationwide Analysis

Incidence and Risk Factors of CMV Reactivation after Haploidentical Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide - Possible Role of Donor KIR Genotypes

Does Early T Cell Chimerism Predict Outcomes after Allogeneic Hematopoietic Cell Transplantation ?

Conditional Survival and Mortality Risks after Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Patients Who Survived Varying Length of Time after Allohct

Pre-Transplant and Peri-d100 Gastrointestinal Dysbiosis Is Associated with the Subsequent Development of Chronic Graft-Versus-Host Disease

Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia

High Incidence of CMV Reactivation after Haploidentical Donor Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide, and Its Impact on Transplant Outcomes

Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Leukemia Cells

Email alerts

ASH Publications

American Society of Hematology